Get Premium to unlock powerful stock data
NAS:UTHR (USA)  
United Therapeutics Corp logo

United Therapeutics Corp

$ 236.11 -1.89 (-0.79%) 02:45 PM EST
P/E:
16.32
P/B:
2.55
Market Cap:
$ 10.69B
Enterprise V:
$ 9.31B
Volume:
146.92K
Avg Vol (2M):
549.47K
Also Trade In:
Volume:
146.92K
Market Cap $:
10.69B
PE Ratio:
16.32
Avg Vol (2-Month):
549.47K
Enterprise Value $:
9.31B
PB Ratio:
2.55
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

United Therapeutics Corp
NAICS : 325412 SIC : 2834
1040 Spring Street, Silver Spring, MD, USA, 20910
Description
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Financials (Next Earnings Date:2022-08-04 Est.)

UTHR's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:UTHR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,768.3
EPS (TTM) ($) 14.45
Beta 0.5
Volatility % 45.92
14-Day RSI 63.08
14-Day ATR ($) 7.690699
20-Day SMA ($) 228.6765
12-1 Month Momentum % 25.25
52-Week Range ($) 158.38 - 243.3
Shares Outstanding (Mil) 45.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

United Therapeutics Corp Filings

Document Form Filing Date
No Filing Data

Headlines

See More